Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 11 of 11 entries
Sorted by: Best Match Show Resources per page
HIV and pulmonary hypertension.

Southern medical journal

Guerin JM, Vidal P.
PMID: 7817237
South Med J. 1995 Jan;88(1):94-5. doi: 10.1097/00007611-199501000-00018.

No abstract available.

Cite
Guerin JM, Vidal P. HIV and pulmonary hypertension. South Med J. 1995;88(1):94-5doi: 10.1097/00007611-199501000-00018.
Guerin, J. M., & Vidal, P. (1995). HIV and pulmonary hypertension. Southern medical journal, 88(1), 94-5. https://doi.org/10.1097/00007611-199501000-00018
Guerin, J M, and Vidal, P. "HIV and pulmonary hypertension." Southern medical journal vol. 88,1 (1995): 94-5. doi: https://doi.org/10.1097/00007611-199501000-00018
Guerin JM, Vidal P. HIV and pulmonary hypertension. South Med J. 1995 Jan;88(1):94-5. doi: 10.1097/00007611-199501000-00018. PMID: 7817237.
Copy Download .nbib Format: NLM
[Primary pulmonary hypertension].

Arquivos brasileiros de cardiologia

de Quadros AS, da Silva PM, Faccin CS, Barreto SS.
PMID: 9497531
Arq Bras Cardiol. 1997 May;68(5):385-90.

No abstract available.

Cite
de Quadros AS, da Silva PM, Faccin CS, et al. Hipertensão pulmonar primária. [Primary pulmonary hypertension]. Arq Bras Cardiol. 1997;68(5):385-90
de Quadros, A. S., da Silva, P. M., Faccin, C. S., & Barreto, S. S. (1997). Hipertensão pulmonar primária. [Primary pulmonary hypertension]. Arquivos brasileiros de cardiologia, 68(5), 385-90.
de Quadros, A S, et al. "Hipertensão pulmonar primária." [Primary pulmonary hypertension]. Arquivos brasileiros de cardiologia vol. 68,5 (1997): 385-90.
de Quadros AS, da Silva PM, Faccin CS, Barreto SS. Hipertensão pulmonar primária. [Primary pulmonary hypertension]. Arq Bras Cardiol. 1997 May;68(5):385-90. Portuguese. PMID: 9497531.
Copy Download .nbib Format: NLM
An incidental finding of occult HIV infection.

Southern medical journal

Cheung WY.
PMID: 17195437
South Med J. 2006 Nov;99(11):1307-8. doi: 10.1097/01.smj.0000247296.37625.d5.

No abstract available.

Cite
Cheung WY. An incidental finding of occult HIV infection. South Med J. 2006;99(11):1307-8doi: 10.1097/01.smj.0000247296.37625.d5.
Cheung, W. Y. (2006). An incidental finding of occult HIV infection. Southern medical journal, 99(11), 1307-8. https://doi.org/10.1097/01.smj.0000247296.37625.d5
Cheung, Winson Y. "An incidental finding of occult HIV infection." Southern medical journal vol. 99,11 (2006): 1307-8. doi: https://doi.org/10.1097/01.smj.0000247296.37625.d5
Cheung WY. An incidental finding of occult HIV infection. South Med J. 2006 Nov;99(11):1307-8. doi: 10.1097/01.smj.0000247296.37625.d5. PMID: 17195437.
Copy Download .nbib Format: NLM
Right Heart Failure-Unrecognized Cause of Cardiorenal Syndrome.

Journal of the American Society of Nephrology : JASN

Bansal S, Prasad A, Linas S.
PMID: 29764920
J Am Soc Nephrol. 2018 Jul;29(7):1795-1798. doi: 10.1681/ASN.2018020224. Epub 2018 May 15.

No abstract available.

Cite
Bansal S, Prasad A, Linas S. Right Heart Failure-Unrecognized Cause of Cardiorenal Syndrome. J Am Soc Nephrol. 2018;29(7):1795-1798doi: 10.1681/ASN.2018020224.
Bansal, S., Prasad, A., & Linas, S. (2018). Right Heart Failure-Unrecognized Cause of Cardiorenal Syndrome. Journal of the American Society of Nephrology : JASN, 29(7), 1795-1798. https://doi.org/10.1681/ASN.2018020224
Bansal, Shweta, et al. "Right Heart Failure-Unrecognized Cause of Cardiorenal Syndrome." Journal of the American Society of Nephrology : JASN vol. 29,7 (2018): 1795-1798. doi: https://doi.org/10.1681/ASN.2018020224
Bansal S, Prasad A, Linas S. Right Heart Failure-Unrecognized Cause of Cardiorenal Syndrome. J Am Soc Nephrol. 2018 Jul;29(7):1795-1798. doi: 10.1681/ASN.2018020224. Epub 2018 May 15. PMID: 29764920; PMCID: PMC6050920.
Copy Download .nbib Format: NLM
ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association.

Circulation

McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J, Harrington RA, Anderson JL, Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Grines CL, Hlatky MA, Jacobs AK, Kaul S, Lichtenberg RC, Lindner JR, Moliterno DJ, Mukherjee D, Pohost GM, Rosenson RS, Schofield RS, Shubrooks SJ, Stein JH, Tracy CM, Weitz HH, Wesley DJ.
PMID: 19332472
Circulation. 2009 Apr 28;119(16):2250-94. doi: 10.1161/CIRCULATIONAHA.109.192230. Epub 2009 Mar 30.

No abstract available.

Cite
McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation. 2009;119(16):2250-94doi: 10.1161/CIRCULATIONAHA.109.192230.
McLaughlin, V. V., Archer, S. L., Badesch, D. B., Barst, R. J., Farber, H. W., Lindner, J. R., Mathier, M. A., McGoon, M. D., Park, M. H., Rosenson, R. S., Rubin, L. J., Tapson, V. F., Varga, J., Harrington, R. A., Anderson, J. L., Bates, E. R., Bridges, C. R., Eisenberg, M. J., Ferrari, V. A., Grines, C. L., Hlatky, M. A., Jacobs, A. K., Kaul, S., Lichtenberg, R. C., Lindner, J. R., Moliterno, D. J., Mukherjee, D., Pohost, G. M., Rosenson, R. S., Schofield, R. S., Shubrooks, S. J., Stein, J. H., Tracy, C. M., Weitz, H. H., Wesley, D. J. (2009). ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation, 119(16), 2250-94. https://doi.org/10.1161/CIRCULATIONAHA.109.192230
McLaughlin, Vallerie V, et al. "ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association." Circulation vol. 119,16 (2009): 2250-94. doi: https://doi.org/10.1161/CIRCULATIONAHA.109.192230
McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J, Harrington RA, Anderson JL, Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Grines CL, Hlatky MA, Jacobs AK, Kaul S, Lichtenberg RC, Lindner JR, Moliterno DJ, Mukherjee D, Pohost GM, Rosenson RS, Schofield RS, Shubrooks SJ, Stein JH, Tracy CM, Weitz HH, Wesley DJ. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation. 2009 Apr 28;119(16):2250-94. doi: 10.1161/CIRCULATIONAHA.109.192230. Epub 2009 Mar 30. PMID: 19332472.
Copy Download .nbib Format: NLM
Pulmonary hypertension associated with congenital heart disease: pulmonary vascular disease: the global perspective.

Chest

Adatia I, Kothari SS, Feinstein JA.
PMID: 20522580
Chest. 2010 Jun;137(6):52S-61S. doi: 10.1378/chest.09-2861.

The incidence of congenital heart disease is approximately 8/1,000 live births and appears to be constant around the world. The currently accepted paradigm for the development of pulmonary vascular disease associated with congenital heart disease maintains that increased pulmonary...

Cite
Adatia I, Kothari SS, Feinstein JA. Pulmonary hypertension associated with congenital heart disease: pulmonary vascular disease: the global perspective. Chest. 2010;137(6):52S-61Sdoi: 10.1378/chest.09-2861.
Adatia, I., Kothari, S. S., & Feinstein, J. A. (2010). Pulmonary hypertension associated with congenital heart disease: pulmonary vascular disease: the global perspective. Chest, 137(6), 52S-61S. https://doi.org/10.1378/chest.09-2861
Adatia, Ian, et al. "Pulmonary hypertension associated with congenital heart disease: pulmonary vascular disease: the global perspective." Chest vol. 137,6 (2010): 52S-61S. doi: https://doi.org/10.1378/chest.09-2861
Adatia I, Kothari SS, Feinstein JA. Pulmonary hypertension associated with congenital heart disease: pulmonary vascular disease: the global perspective. Chest. 2010 Jun;137(6):52S-61S. doi: 10.1378/chest.09-2861. PMID: 20522580.
Copy Download .nbib Format: NLM
Worldwide physician education and training in pulmonary hypertension: pulmonary vascular disease: the global perspective.

Chest

Elliott CG, Barst RJ, Seeger W, Porres-Aguilar M, Brown LM, Zamanian RT, Rubin LJ.
PMID: 20522584
Chest. 2010 Jun;137(6):85S-94S. doi: 10.1378/chest.09-2816.

Pulmonary hypertension (PH) affects > 25 million individuals worldwide and causes premature disability and death for many. The diagnosis and treatment of PH have advanced dramatically through the development of a clearly defined diagnostic classification, an evidence-based treatment algorithm...

Cite
Elliott CG, Barst RJ, Seeger W, et al. Worldwide physician education and training in pulmonary hypertension: pulmonary vascular disease: the global perspective. Chest. 2010;137(6):85S-94Sdoi: 10.1378/chest.09-2816.
Elliott, C. G., Barst, R. J., Seeger, W., Porres-Aguilar, M., Brown, L. M., Zamanian, R. T., & Rubin, L. J. (2010). Worldwide physician education and training in pulmonary hypertension: pulmonary vascular disease: the global perspective. Chest, 137(6), 85S-94S. https://doi.org/10.1378/chest.09-2816
Elliott, C Gregory, et al. "Worldwide physician education and training in pulmonary hypertension: pulmonary vascular disease: the global perspective." Chest vol. 137,6 (2010): 85S-94S. doi: https://doi.org/10.1378/chest.09-2816
Elliott CG, Barst RJ, Seeger W, Porres-Aguilar M, Brown LM, Zamanian RT, Rubin LJ. Worldwide physician education and training in pulmonary hypertension: pulmonary vascular disease: the global perspective. Chest. 2010 Jun;137(6):85S-94S. doi: 10.1378/chest.09-2816. PMID: 20522584.
Copy Download .nbib Format: NLM
Trends in pulmonary arterial hypertension.

European respiratory review : an official journal of the European Respiratory Society

Souza R, Jardim C.
PMID: 20956116
Eur Respir Rev. 2009 Mar;18(111):7-12. doi: 10.1183/09059180.00011103.

No abstract available.

Cite
Souza R, Jardim C. Trends in pulmonary arterial hypertension. Eur Respir Rev. 2009;18(111):7-12doi: 10.1183/09059180.00011103.
Souza, R., & Jardim, C. (2009). Trends in pulmonary arterial hypertension. European respiratory review : an official journal of the European Respiratory Society, 18(111), 7-12. https://doi.org/10.1183/09059180.00011103
Souza, R, and Jardim, C. "Trends in pulmonary arterial hypertension." European respiratory review : an official journal of the European Respiratory Society vol. 18,111 (2009): 7-12. doi: https://doi.org/10.1183/09059180.00011103
Souza R, Jardim C. Trends in pulmonary arterial hypertension. Eur Respir Rev. 2009 Mar;18(111):7-12. doi: 10.1183/09059180.00011103. PMID: 20956116.
Copy Download .nbib Format: NLM
[Pathogenesis of chronic thromboembolic pulmonary hypertension].

Zhonghua yi xue za zhi

Zhai ZG, Wang J.
PMID: 22944227
Zhonghua Yi Xue Za Zhi. 2012 Jul 10;92(26):1807-9.

No abstract available.

Cite
Zhai ZG, Wang J. [Pathogenesis of chronic thromboembolic pulmonary hypertension]. Zhonghua Yi Xue Za Zhi. 2012;92(26):1807-9
Zhai, Z. G., & Wang, J. (2012). [Pathogenesis of chronic thromboembolic pulmonary hypertension]. Zhonghua yi xue za zhi, 92(26), 1807-9.
Zhai, Zhen-guo, and Wang, Jun. "[Pathogenesis of chronic thromboembolic pulmonary hypertension]." Zhonghua yi xue za zhi vol. 92,26 (2012): 1807-9.
Zhai ZG, Wang J. [Pathogenesis of chronic thromboembolic pulmonary hypertension]. Zhonghua Yi Xue Za Zhi. 2012 Jul 10;92(26):1807-9. Chinese. PMID: 22944227.
Copy Download .nbib Format: NLM
Pathophysiology and potential treatments of pulmonary hypertension due to systolic left heart failure.

Acta physiologica (Oxford, England)

Lundgren J, Rådegran G.
PMID: 24703457
Acta Physiol (Oxf). 2014 Jun;211(2):314-33. doi: 10.1111/apha.12295.

Pulmonary hypertension (PH) due to left heart failure is becoming increasingly prevalent and is associated with poor outcome. The precise pathophysiological mechanisms behind PH due to left heart failure are, however, still unclear. In its early course, PH is...

Cite
Lundgren J, Rådegran G. Pathophysiology and potential treatments of pulmonary hypertension due to systolic left heart failure. Acta Physiol (Oxf). 2014;211(2):314-33doi: 10.1111/apha.12295.
Lundgren, J., & Rådegran, G. (2014). Pathophysiology and potential treatments of pulmonary hypertension due to systolic left heart failure. Acta physiologica (Oxford, England), 211(2), 314-33. https://doi.org/10.1111/apha.12295
Lundgren, J, and Rådegran, G. "Pathophysiology and potential treatments of pulmonary hypertension due to systolic left heart failure." Acta physiologica (Oxford, England) vol. 211,2 (2014): 314-33. doi: https://doi.org/10.1111/apha.12295
Lundgren J, Rådegran G. Pathophysiology and potential treatments of pulmonary hypertension due to systolic left heart failure. Acta Physiol (Oxf). 2014 Jun;211(2):314-33. doi: 10.1111/apha.12295. PMID: 24703457.
Copy Download .nbib Format: NLM
COVID-19 and Pulmonary Hypertension in Children: What Do We Know So Far?.

Medicina (Kaunas, Lithuania)

Das BB.
PMID: 33352654
Medicina (Kaunas). 2020 Dec 19;56(12). doi: 10.3390/medicina56120716.

The interplay between coronavirus disease 2019 (COVID-19) and pulmonary hypertension (PH) in children is unknown. Adults with PH are at potential risk for severe complications and high mortality due to associated comorbidities. It is difficult to extrapolate the outcomes...

Cite
Das BB. COVID-19 and Pulmonary Hypertension in Children: What Do We Know So Far?. Medicina (Kaunas). 2020;56(12)doi: 10.3390/medicina56120716.
Das, B. B. (2020). COVID-19 and Pulmonary Hypertension in Children: What Do We Know So Far?. Medicina (Kaunas, Lithuania), 56(12), . https://doi.org/10.3390/medicina56120716
Das, Bibhuti B. "COVID-19 and Pulmonary Hypertension in Children: What Do We Know So Far?." Medicina (Kaunas, Lithuania) vol. 56,12 (2020). doi: https://doi.org/10.3390/medicina56120716
Das BB. COVID-19 and Pulmonary Hypertension in Children: What Do We Know So Far?. Medicina (Kaunas). 2020 Dec 19;56(12). doi: 10.3390/medicina56120716. PMID: 33352654; PMCID: PMC7765781.
Copy Download .nbib Format: NLM
Showing 1 to 11 of 11 entries